IGF2 and prostate cancer: Loss of IGF-II imprinting has been reported in the normal colonic mucosa of around 30 % of patients with colorectal cancer [122] and loss of IGF-II imprinting has been observed also throughout the normal prostate in just under 40 % of men with prostate cancer [123].